Peter Francis - Dec 9, 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director
Signature
/s/ Peter Francis
Stock symbol
BNTC
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 05:24 PM
Previous filing
Dec 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNTC Options (right to buy) Award $0 +35K $0.00 35K Dec 9, 2024 Common Stock 35K $12.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.